SynchNeuro develops wearable neurotechnology designed to monitor metabolic and physiological health through non-invasive EEG signals. The company’s platform is delivered as a behind-the-ear device that continuously records brain activity to infer biomarkers related to blood glucose, sleep quality, and overall metabolic state. Its approach emphasizes unobtrusive, at-home monitoring without the need for invasive sensors. SynchNeuro positions its technology within applied neuroscience and digital health contexts.

The technology captures EEG signals and applies AI-driven analytics to detect patterns correlated with metabolic and sleep-related metrics. By analyzing neural activity alongside temporal patterns, the system estimates blood glucose trends, sleep quality, and other indicators of metabolic health. The wearable design allows continuous monitoring in everyday settings, supporting longitudinal assessment. This approach prioritizes accessibility and real-time insight over direct clinical measurement.

SynchNeuro targets individuals seeking non-invasive monitoring for metabolic health, sleep optimization, and preventive wellness. The platform is positioned outside regulated medical treatment and is intended for personal health tracking and lifestyle applications. Its focus reflects growing interest in leveraging neural signals as proxies for systemic physiological states in wearable devices.